Cargando…

Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma

Background: Metastatic melanoma has poor therapeutic response and may present resistance to chemotherapy or immunotherapy. Significant differences are observed in the survival time of patients with metastatic melanoma based on the administration of chemotherapy or immunotherapy; thus, we have explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Gao, Yuling, Chu, Weiling, Lv, Jianjian, Li, Zhi, Shi, Tongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580330/
https://www.ncbi.nlm.nih.gov/pubmed/34675134
http://dx.doi.org/10.18632/aging.203640